Shree Ram Proteins Limited
All news and filings related to Shree Ram Proteins Limited.
View all news & filings- High impact
Shree Ram Proteins Board Meeting Outcome: Approves Q1 FY27 & FY26 Financials amidst Going Concern Uncertainty
Shree Ram Proteins Limited's Board Meeting on August 17, 2026, approved unaudited Q1 FY27 results and audited FY26 results. The company faces severe financial distress, with defaults on loans and statutory dues. Auditors issued an adverse opinion due to going concern uncertainties, noting auction of plant and machinery and failure to meet OTS installments.
Read the summary - High impact
Shree Ram Proteins Ltd. Special Resolution for Disposal of Undertaking Passed
Shree Ram Proteins Limited's postal ballot results show the special resolution for the disposal of the company's undertaking has been passed. The resolution received overwhelming support with 17,656,004 votes in favour out of 17,675,333 total votes cast. E-voting concluded on September 09, 2026.
Read the summary - Low impact
SRPL Files SEBI Compliance Certificate for Quarter Ended June 30, 2026
Shree Ram Proteins Limited submitted a compliance certificate for Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The certificate, issued by MUFG Intime India Pvt. Ltd. for the quarter ended June 30, 2026, confirms proper processing of dematerialised securities.
Read the summary - High impact
Shree Ram Proteins Limited: EOGM Approves Sale of Undertaking and Capital Raise via QIP
Shree Ram Proteins Limited's EOGM on March 5, 2026, approved the sale of its undertaking and a Qualified Institutions Placement (QIP). The sale of undertaking received 7,714,361 favourable votes, while the QIP saw 16,433,040 favourable votes.
Read the summary - High impact
Shree Ram Proteins Board Meeting: Approves Q1 FY27 Unaudited & FY26 Audited Results; Faces Financial Woes
Shree Ram Proteins Limited's Board met on August 17, 2026, approving unaudited results for Q1 FY27 and audited results for FY26. The company faces significant financial distress, with auditors issuing an adverse opinion due to going concern uncertainties, loan defaults, and auction of assets.
Read the summary - High impact
Shree Ram Proteins Board Meeting: Approves Q1 FY27 & FY26 Results, Faces Going Concern Uncertainty
Shree Ram Proteins board met on August 17, 2026, approving Q1 FY27 unaudited and FY26 audited results. The company faces severe financial distress, with auditors issuing an adverse opinion due to a material uncertainty regarding its going concern status. Defaults on loans and statutory dues are reported, alongside a significant working capital shortage.
Read the summary - Low impact
Shree Ram Proteins Ltd. Publishes Postal Ballot Notice in Newspapers
Shree Ram Proteins Limited published its Postal Ballot Notice on August 11, 2026, in "Financial Express" (English and Gujarati). The notice and remote e-voting instructions are available on the company's website.
Read the summary - Medium impact
Shree Ram Proteins seeks shareholder approval for property sale at ₹17 Crore via postal ballot
Shree Ram Proteins is seeking shareholder approval for the sale of a property for approximately ₹17 Crore. The company has issued a postal ballot notice, with remote e-voting available from August 11, 2026, to September 9, 2026. Results are expected by September 11, 2026.
Read the summary - High impact
Shree Ram Proteins Board Approves Sale of Undertaking for ₹17 Crore
Shree Ram Proteins' Board approved the sale of substantially the whole undertaking for approximately ₹17 crore. Shareholder approval will be sought via postal ballot. Ms. Payal Dhamecha appointed as Scrutinizer for the postal ballot process.
Read the summary - High impact
Shree Ram Proteins Board Approves Sale of Undertaking for ₹17 Crore
Shree Ram Proteins Limited's Board approved the sale of substantially the whole undertaking for ₹17 Crore. Shareholder approval will be sought via Postal Ballot. Ms. Payal Dhamecha appointed as Scrutinizer.
Read the summary - High impact
Shree Ram Proteins Limited: Auditors Issue Adverse Opinion on FY25 Financials
Shree Ram Proteins Limited's auditors issued an adverse opinion on the FY25 annual financial results. Key issues include going concern uncertainties due to loan defaults, ongoing CIRP, and failure to provide sufficient audit evidence. The company also defaulted on a One-Time Settlement with Union Bank of India.
Read the summary - Low impact
Shree Ram Proteins Closes Trading Window from July 1, 2026, for Q1 FY27 Results
Shree Ram Proteins Limited will close its trading window from July 1, 2026. The window will reopen 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2026. The Board Meeting date for results declaration will be announced later.
Read the summary - Low impact
SRPL Submits SEBI Compliance Certificate for Q4 FY26
Shree Ram Proteins Limited submitted a compliance certificate for Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The certificate, issued by RTA MUFG Intime India Pvt. Ltd, confirms processing of dematerialisation requests for the quarter ended March 31, 2026.
Read the summary - Low impact
Shree Ram Proteins Limited: Trading Window Closes April 1st for Q4 FY26 Results
Shree Ram Proteins Limited will close its trading window from April 1st, 2026. This is to facilitate the declaration of audited financial results for the quarter and year ended March 31st, 2026. The window will reopen 48 hours after the results are declared.
Read the summary - High impact
SRPL Completes Annual Report Filings, Seeks Revocation of Trading Suspension
Shree Ram Proteins Limited has completed the submission of its Annual Reports for FY 2023-24 and FY 2024-25 on February 11, 2026. The company is also filing a compounding petition for the delay in its Annual General Meeting. SRPL has requested the revocation of its trading suspension.
Read the summary - Medium impact
Shree Ram Proteins Sells Land for ₹30 Crore in Related Party Transaction
Shree Ram Proteins Limited approved the sale of land for up to ₹30 crore to Sova Agrotech Private Limited. The EGM on March 5, 2026, approved the transaction, which is a related party deal. Completion is expected by April 2026.
Read the summary - Medium impact
Shree Ram Proteins Limited EOGM Approves Sale of Undertaking and Capital Raise
Shree Ram Proteins Limited held an EOGM on March 05, 2026. Shareholders approved the sale of an undertaking as a related party transaction and authorized capital raising via Qualified Institutions Placement (QIP). Both resolutions received strong majority support from shareholders.
Read the summary - Low impact
Shree Ram Proteins Ltd: AGM Voting Results Show Strong Shareholder Support
Shree Ram Proteins Limited's 17th AGM was held on March 5, 2026, via VC. All resolutions, including financial statement adoption, director appointments, capital increase, and borrowing powers, passed with overwhelming shareholder support. The company submitted voting results and the Scrutinizer's Report on March 6, 2026.
Read the summary - Medium impact
Shree Ram Proteins Limited Concludes 16th AGM with Overwhelming Support for Resolutions
Shree Ram Proteins Limited held its 16th AGM on March 05, 2026, via VC/OAVM. Shareholders overwhelmingly approved resolutions including the adoption of FY24 financial statements, re-appointment of a director, and appointment of two new independent directors. Remuneration for the cost auditor was also ratified.
Read the summary - Medium impact
Shree Ram Proteins Limited Holds EOGM for Sale of Undertaking & QIP.
Shree Ram Proteins Limited held an EOGM on March 5, 2026, to approve the sale of an undertaking as a material related party transaction and to raise capital via Qualified Institutions Placement (QIP). The results of e-voting will be announced separately.
Read the summary - Low impact
Shree Ram Proteins Limited Holds 17th AGM on March 5, 2026, Approves Financials and Director Appointments
Shree Ram Proteins Limited held its 17th AGM on March 5, 2026. Key resolutions included adopting FY25 financials, appointing directors, increasing authorized share capital, and appointing secretarial auditors for five years. The board also received authority to borrow money.
Read the summary - Low impact
Shree Ram Proteins Limited Holds 16th AGM on March 5, 2026
Shree Ram Proteins Limited held its 16th AGM on March 5, 2026. Key resolutions included adopting FY24 financial statements, appointing directors, and ratifying cost auditor remuneration for FY25. E-voting results will be announced separately.
Read the summary - Medium impact
Shree Ram Proteins Limited: Corrigendum & Addendum to AGM Notice and Annual Report 2024-25
Shree Ram Proteins Limited issued a corrigendum and addendum to its 17th AGM notice and Annual Report 2024-25. The AGM is on March 5, 2026. The corrigendum clarifies director reappointment for Mr. Piyush Vasoya. The FY 2024-25 results show zero revenue from operations and a loss after tax of ₹(2,107.51) Lakhs.
Read the summary - Low impact
Shree Ram Proteins Ltd. Corrigendum for 17th AGM Notice and Annual Report 2024-25
Shree Ram Proteins Limited has issued a corrigendum and addendum for its 17th Annual General Meeting (AGM) notice and Annual Report 2024-25. The AGM is scheduled for March 5, 2026. The corrigendum clarifies director appointment details, and the addendum includes the Secretarial Audit Report.
Read the summary - Medium impact
Shree Ram Proteins plans EGM for asset sale up to ₹30 Cr and ₹100 Cr QIP
Shree Ram Proteins Limited announced an EGM on March 5, 2026, to approve selling its undertaking for up to ₹30 crore to Sova Agrotech Private Limited. Additionally, the company plans to raise up to ₹100 crore via QIP for business growth. Remote e-voting is open from March 2-4, 2026.
Read the summary - Medium impact
Shree Ram Proteins to hold 17th AGM on March 5, 2026; to approve FY25 results & increase authorized capital
Shree Ram Proteins Limited will hold its 17th AGM on March 5, 2026, via VC/OAVM. Key agenda items include approving FY25 financial results, increasing authorized share capital to ₹125 crore, and appointing two new Independent Directors. The company will also seek approval for borrowing up to ₹500 crore and to dispose of assets.
Read the summary - Low impact
Shree Ram Proteins Limited Announces 16th AGM on March 5, 2026, with E-voting from March 2-4
Shree Ram Proteins Limited will hold its 16th AGM on March 5, 2026, via VC/OAVM. The agenda includes adopting FY24 audited financials, reappointing Mr. Navin Kumar Singh, and regularizing directors Mr. Akash Sureshbai Gajera and Mr. Yogesh Chandubhai Dhanani. Remote e-voting is available from March 2-4, 2026.
Read the summary - Low impact
Shree Ram Proteins Ltd. Publishes Financial Results for Q3 FY26
Shree Ram Proteins Limited has announced its un-audited financial results for the quarter ended December 31, 2025. The company published the results in English and Gujarati newspapers on February 7, 2026, complying with SEBI regulations.
Read the summary - Medium impact
Shree Ram Proteins: 3 Additional Independent Directors Cease Office Due to Delayed AGM
Three Additional Independent Directors, Ms. Naaz Jaiswal, Mr. Akash Sureshbhai Gajera, and Mr. Yogeshbhaichandubhai Dhanani, have ceased their roles at Shree Ram Proteins Limited. This cessation is effective from the due date of the AGM, as the company failed to hold its AGM within the statutory timeline.
Read the summary - High impact
SRPL Board Approves ₹100 Crore Fundraising, Appoints Directors, Schedules AGM
Shree Ram Proteins Limited (SRPL) approved its Q3 FY2026 results and plans to raise ₹100 crore. The company will appoint four new directors and scheduled its 15th, 16th AGMs and an EGM for March 5, 2026. A portion of funds will be used for acquiring Sova Agrotech. However, auditors flagged material uncertainty about the company's going concern status due to defaults.
Read the summary - Low impact
SRPL Submits SEBI Compliance Certificate for Q1 FY26
Shree Ram Proteins Limited submitted a SEBI compliance certificate for the quarter ended June 30, 2025. The certificate confirms the dematerialization and rematerialization of securities as per SEBI regulations. This was confirmed by the RTA, MUFG Intime India Private Limited.
Read the summary - Low impact
SRPL Submits SEBI Regulation 74(5) Certificate for Q2 FY26
Shree Ram Proteins Limited submitted its SEBI Regulation 74(5) certificate for the quarter ended September 30, 2025. The RTA, MUFG Intime India Private Limited, confirmed processing of dematerialized securities.
Read the summary - Low impact
Shree Ram Proteins Appoints Payal Dhamecha & Associates as Secretarial Auditor
Shree Ram Proteins Limited's Board meeting on January 28, 2026, approved the appointment of M/s. Payal Dhamecha & Associates as Secretarial Auditor for FY 2025-2026. The firm will serve a one-year term.
Read the summary - Low impact
Shree Ram Proteins Files SEBI Compliance Certificate for Q3 FY26
Shree Ram Proteins Limited submitted a SEBI compliance certificate for the quarter ended December 31, 2025. The company confirmed the processing of dematerialized securities as per SEBI regulations.
Read the summary - Low impact
Shree Ram Proteins Closes Trading Window from Jan 1, 2026 for Q3 FY26 Results
Shree Ram Proteins Limited will close its trading window from January 1, 2026. The window will reopen 48 hours after the declaration of the Un-Audited Financial Results for the quarter ending December 31, 2025. This is to comply with SEBI insider trading regulations.
Read the summary - High impact
SRPL Board approves Sep 2025 results; Auditor raises going concern doubts, highlights loan defaults
SRPL's Board approved half-yearly results for Sep 2025. Auditors issued a qualified opinion due to going concern uncertainty, loan defaults, unpaid statutory dues, and failure to meet one-time settlement terms.
Read the summary - Low impact
Shree Ram Proteins defers proposals for capital increase and preferential share issue
Shree Ram Proteins' board meeting on November 4, 2025, deferred proposals to increase authorized share capital and raise funds via preferential issue to a future meeting.
Read the summary - High impact
Shree Ram Proteins Faces Going Concern Doubts; Auditors Issue Adverse Opinion on Q1 FY26 Results
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio - Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio